We are live on ! Find out more
LYRA

LYRA THERAPEUTICS INC

Delisted

LYRA was delisted on the 16th of March, 2026.

26 hedge funds and large institutions have $2.93M invested in LYRA THERAPEUTICS INC in 2025 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 4 increasing their positions, 13 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

0% more funds holding in top 10

Funds holding in top 10: 11 (0)

10% less ownership

Funds ownership: 37.28%27.28% (-10%)

13% less funds holding

Funds holding: 3026 (-4)

34% less capital invested

Capital invested by funds: $4.42M → $2.93M (-$1.49M)

50% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 8

69% less repeat investments, than reductions

Existing positions increased: 4 | Existing positions reduced: 13

Holders
26
Holders Change
-4
Holders Change %
-13.33%
% of All Funds
0.34%
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.01%
New
4
Increased
4
Reduced
13
Closed
8
Calls
Puts
Net Calls
Net Calls Change

LYRA Hedge Fund Activity: Q3 2025 in Review

26 of the 7,624 institutional investors tracked by Wall St. Rank reported a position in LYRA THERAPEUTICS INC (LYRA) for Q3 2025, worth a combined $2.93M — down 34% from $4.42M a quarter earlier.

Sellers outnumbered buyers: 8 funds closed out of LYRA and 4 opened new positions — a net loss of 4 holders — while 13 trimmed existing stakes and 4 added.

The largest buyer was Citadel Advisors, opening a new position worth an estimated $143K. The largest seller was Bank of America, cutting an estimated $209K.

  • 26 institutional investors held LYRA THERAPEUTICS INC (LYRA) as of Q3 2025, down from 30 in Q2 2025.
  • Funds reported $2.93M of LYRA THERAPEUTICS INC stock for Q3 2025, down 34% quarter-over-quarter.
  • 4 funds opened new LYRA THERAPEUTICS INC positions in Q3 2025 and 8 closed out, a net change of -4 holders.
  • The largest LYRA THERAPEUTICS INC buyer in Q3 2025 was Citadel Advisors, an estimated $143K added.
  • The largest LYRA THERAPEUTICS INC seller in Q3 2025 was Bank of America, an estimated $209K sold.

Based on aggregated 13F filings for Q3 2025.